Author:
Devineni D.,Morrow L.,Hompesch M.,Skee D.,Vandebosch A.,Murphy J.,Ways K.,Schwartz S.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference10 articles.
1. Liang Y Arakawa K Martin T et al. JNJ-28431754/TA-7284, an SGLT inhibitor, lowers blood glucose and reduces body weight in obese and type 2 diabetic animal models th
2. Liang Y Du F Conway J et al. Effect of canagliflozin on renal threshold for glucose excretion in diabetic animals
3. Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects.;Sha;Diabetes Obes Metab,2011
4. Sha S Devineni D Ghosh A et al. Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, improved glucose control in subjects with type 2 diabetes and was well tolerated (Abstract #568-P). FL
5. Seventy-five gram glucose tolerance test to assess carbohydrate malabsorption and small bowel bacterial overgrowth.;Urita;World J Gastroenterol,2006
Cited by
198 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献